SMTL ID : 4bb5.1 (1 other biounit)

Free-Wilson and Structural Approaches to Co-optimising Human and Rodent Isoform Potency for 11b-Hydroxysteroid Dehydrogenase Type 1 11b-HSD1 Inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 30 residues within 4Å: Chain A: G.41, A.42, S.43, K.44, G.45, I.46, A.65, R.66, S.67, G.91, T.92, M.93, E.94, N.119, H.120, I.121, Y.147, V.168, S.169, S.170, Y.183, K.187, L.215, G.216, L.217, I.218, T.220, T.222, A.223 Ligands: HD2.2 30 PLIP interactions: 30 interactions with chain A Hydrophobic interactions: A:L.215, A:I.218 Hydrogen bonds: A:G.41, A:S.43, A:S.43, A:S.43, A:K.44, A:I.46, A:R.66, A:S.67, A:T.92, A:M.93, A:N.119, A:I.121, A:Y.183, A:K.187, A:I.218, A:T.220, A:T.220 Water bridges: A:G.47, A:N.119, A:T.122, A:T.122, A:N.123, A:N.123, A:N.123, A:N.123, A:T.222 Salt bridges: A:K.44, A:R.66 NAP.3: 31 residues within 4Å: Chain B: G.41, A.42, S.43, K.44, G.45, I.46, A.65, R.66, S.67, G.91, T.92, M.93, E.94, N.119, H.120, I.121, N.123, Y.147, V.168, S.169, S.170, Y.183, K.187, L.215, G.216, L.217, I.218, T.220, T.222, A.223 Ligands: HD2.4 27 PLIP interactions: 27 interactions with chain B Hydrophobic interactions: B:L.215 Hydrogen bonds: B:G.41, B:S.43, B:S.43, B:S.43, B:K.44, B:I.46, B:R.66, B:S.67, B:T.92, B:M.93, B:E.94, B:N.119, B:Y.183, B:K.187, B:I.218, B:T.220, B:T.220, B:T.220, B:T.222 Water bridges: B:G.47, B:N.119, B:N.123, B:N.123, B:T.222 Salt bridges: B:K.44, B:R.66

2 x HD2: 4-CYCLOPENTYL-N-[(1S,3R)-5-OXIDANYL-2-ADAMANTYL]-2-[[(3S)-OXOLAN-3-YL]AMINO]PYRIMIDINE-5-CARBOXAMIDE(Non-covalent)

HD2.2: 19 residues within 4Å: Chain A: I.121, T.124, L.126, S.170, L.171, Y.177, P.178, V.180, Y.183, L.215, G.216, L.217, T.222, A.223, A.226, V.231 Chain B: Y.280, Y.284 Ligands: NAP.1 14 PLIP interactions: 1 interactions with chain B, 13 interactions with chain A Hydrogen bonds: B:Y.284, A:T.124, A:S.170, A:Y.177 Hydrophobic interactions: A:L.126, A:Y.177, A:V.180, A:V.180, A:Y.183, A:Y.183, A:A.223, A:A.226, A:V.231, A:V.231 HD2.4: 19 residues within 4Å: Chain A: Y.280, Y.284 Chain B: I.121, T.124, L.126, S.170, L.171, Y.177, P.178, V.180, Y.183, L.215, G.216, L.217, T.222, A.223, A.226, V.231 Ligands: NAP.3 12 PLIP interactions: 11 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:L.126, B:Y.177, B:V.180, B:V.180, B:Y.183, B:Y.183, B:A.223, B:A.226, A:Y.284 Hydrogen bonds: B:T.124, B:S.170, B:Y.177

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Goldberg, F.W. et al., Free-Wilson and Structural Approaches to Co-Optimising Human and Rodent Isoform Potency for 11Beta-Hydroxysteroid Dehydrogenase Type 1 (11Beta-Hsd1) Inhibitors. J.Med.Chem. (2012)

Release Date

2012-11-28

Peptides

CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1

Related Entries With Identical Sequence